NEXPHORIA
KLW Stack
KPV + LL-37 + Thymosin Alpha-1. Triple immune-modulation and gut-barrier protocol.
Purchase Type
Fresh cold-chain delivery every 30 days
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
KLW is a three-compound immune and mucosal defense research protocol combining KPV (anti-inflammatory MSH tripeptide), LL-37 (human cathelicidin AMP), and Thymosin Alpha-1 (thymic T-cell activator). Together they address inflammation (KPV), innate antimicrobial defense (LL-37), and adaptive immune competence (Thymosin Alpha-1) across overlapping but complementary pathways.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare KLW Stack with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Wellness
This itemKLW Stack
80mg protocol
$60
Wellness
RecommendedNAD+
100mg
$30
Recovery & Healing
KPV
10mg
$58
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
KLW Stack: KPV + LL-37 + Thymosin Alpha-1 Triple Immune Modulation Research Guide
Comprehensive research guide to the KLW triple immune stack covering three orthogonal immune pathways — NF-κB suppression (KPV), innate antimicrobial defense (LL-37), and adaptive T-cell activation (Thymosin Alpha-1). Protocol design, dosing, endpoints, and synergy rationale.
Peptide Immunology Research: TLR Signaling, Cytokine Assays, and NF-κB Endpoints
A comprehensive methodology guide for immunology-focused peptide research: TLR signaling pathways activated by Thymosin Alpha-1, KPV, and LL-37; cytokine assay selection (ELISA vs multiplex Luminex); NF-κB reporter design; PBMC and splenocyte protocols; NK cytotoxicity; and critical experimental controls.
KPV: The Immunomodulatory Tripeptide
A research-focused guide to KPV — its origin as the C-terminal fragment of alpha-MSH, MC1R/MC3R binding without pigmentation, NF-κB inhibition, anti-inflammatory cytokine suppression, intestinal mucosal research models, oral stability, and design considerations for immunology and GI research.
Complete Your Protocol
Longevity Stack
KLW Blend's longevity peptide combination is complemented by NAD+ to address mitochondrial energy metabolism alongside epigenetic aging markers.
Wellness
KLW Stack
80mg protocol
$60
Wellness
NAD+
100mg
$30